Isoray to Present at the Oppenheimer 31st Annual Healthcare Conference
March 03 2021 - 8:13AM
Isoray, Inc. (NYSE American: ISR), a medical technology company and
seed brachytherapy innovator, today announced that Chief Executive
Officer Lori Woods will present at the Oppenheimer 31st Annual
Healthcare Conference on Wednesday, March 17 at 11:20 a.m. ET. CEO
Woods and Chief Financial Officer Jonathan Hunt will also host
virtual one-on-one and group meetings with institutional investors
during the conference.
A live webcast of the presentation will be
available on Isoray’s Investor Relations section of the Company’s
website at https://isoray.com/investors/presentations/. An
on-demand replay of the presentation will be available shortly
after the conclusion of the presentation on the Investor Relations
section of the website and will be available for 90 days.
About IsorayIsoray, Inc., through its
subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131
brachytherapy seeds, which are expanding brachytherapy options
throughout the body. Learn more about this innovative Richland,
Washington company and explore the many benefits and uses of
Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and
Twitter. Join us on Facebook.
Contact:
Investor Relations: Mark Levin (501) 255-1910
Media and Public Relations: Sharon Schultz (302) 539-3747
IsoRay (AMEX:ISR)
Historical Stock Chart
From Mar 2024 to Apr 2024
IsoRay (AMEX:ISR)
Historical Stock Chart
From Apr 2023 to Apr 2024